ArticleFrontiers in cardiovascular medicine2022

First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction.

Lien-Cheng Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.